LY-344864

From Wikipedia, the free encyclopedia

Other namesLY344864; LY-344,864
CAS Number
LY-344864
Clinical data
Other namesLY344864; LY-344,864
Identifiers
  • N-[(6R)-6-(dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H22FN3O
Molar mass351.425 g·mol−1
3D model (JSmol)
  • CN(C)[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)NC(=O)C4=CC=C(C=C4)F
  • InChI=1S/C21H22FN3O/c1-25(2)16-8-10-20-18(12-16)17-11-15(7-9-19(17)24-20)23-21(26)13-3-5-14(22)6-4-13/h3-7,9,11,16,24H,8,10,12H2,1-2H3,(H,23,26)/t16-/m1/s1
  • Key:GKWHICIUSVVNGX-MRXNPFEDSA-N

LY-344864 is an experimental drug of the triptan and tetrahydrocarbazolamine families with a tricyclic cyclized tryptamine structure which acts as an agonist for the 5-HT1F serotonin receptor.[1] It has antimigraine activity in animal models but was never developed for this indication as a medicine,[2][3] however it continues to be used in scientific research and in recent years has been investigated as a potential agent for stimulating mitochondrial biogenesis, which can facilitate repair to damaged cells and tissues with a number of potential medical applications.[4][5][6][7][8]

References

Related Articles

Wikiwand AI